|
Video: What is a Stock Split?
|
|
Alzamend Neuro is a specialty pharmaceutical company engaged in the development and commercialization of patented intellectual property to prevent, treat and cure Alzheimer's disease ("Alzheimer's" or "AD"). Co. has licensed an immunotherapy vaccine peptide that works both as a treatment and vaccine against Alzheimer's and an ionic cocrystal of lithium to mitigate extreme agitation and forestall other deterioration as displayed by patients with up to moderate AD and possibly other neurodegenerative diseases. Co. devotes substantially all its efforts towards research and development of its Technology and raising capital. According to our ALZN split history records, Alzamend Neuro has had 1 split. | |
|
Alzamend Neuro (ALZN) has 1 split in our ALZN split history database. The split for ALZN took place on October 31, 2023. This was a 1 for 15 reverse split, meaning for each 15 shares of ALZN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Alzamend Neuro conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ALZN split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alzamend Neuro shares, starting with a $10,000 purchase of ALZN, presented on a split-history-adjusted basis factoring in the complete ALZN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/16/2021 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$155.25 |
|
End price/share: |
$0.72 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.54% |
|
Average Annual Total Return: |
-84.57% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$46.26 |
|
Years: |
2.88 |
|
|
|
Date |
Ratio |
10/31/2023 | 1 for 15 |
|
|